Trials / Terminated
TerminatedNCT01357629
Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease
Observational Follow-up Extension Study to Evaluate Long-term Safety and Tolerability of Immunizations With AFFITOPE AD02 Applied During AFFiRiS002 and AFF004A in Patients With Alzheimer's Disease
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 11 (actual)
- Sponsor
- Affiris AG · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study examines the long term Safety Follow-up of first patients vaccinated with AD02.
Detailed description
Patients who have received AD02 during AFF002 and AFF004A will be observed.
Conditions
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2013-04-01
- Completion
- 2013-11-01
- First posted
- 2011-05-23
- Last updated
- 2013-12-11
Locations
2 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT01357629. Inclusion in this directory is not an endorsement.